Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.73 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.73 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.73 |
| ▸ | P2RX2 | Q9UBL9 | 3/20 | 0.73 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | P2RX5 | Q93086 | 2/20 | 0.73 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.73 |
| ▸ | CASP1 | P29466 | 1/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | RAB9A | P51151 | 1/20 | 0.73 |
| ▸ | CASP7 | P55210 | 1/20 | 0.73 |
| ▸ | YWHAG | P61981 | 1/20 | 0.66 |
| ▸ | YWHAZ | P63104 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7095169 | 0.92 | P2RX7 (0.65) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7096181 | 0.90 | P2RX7 (0.63) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7091084 | 0.89 | P2RY1 (0.61) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7091071 | 0.89 | P2RY1 (0.73) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7094330 | 0.88 | P2RY1 (0.60) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7094745 | 0.88 | P2RX7 (0.60) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7096454 | 0.87 | P2RX7 (0.59) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7095508 | 0.86 | P2RX7 (0.59) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7111733 | 0.86 | P2RX7 (0.58) | MAPTTDP1P2RY1KDM4EP2RX7 | |
| SCHEMBL7144031 | 0.85 | P2RX7 (0.55) | MAPTTDP1P2RY1KDM4EP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9872875-B2 | Component and method for treating viral disease | HONZ PHARMACEUTICAL CO., LTD. (CN) | 2018-01-23 | — | — | US | disclosed |
| US-20150045318-A1 | COMPONENT AND METHOD FOR TREATING VIRAL DISEASE | HONZ PHARMACEUTICAL CO., LTD. (CN) | 2015-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045318-A1 | COMPONENT AND METHOD FOR TREATING VIRAL DISEASE | P2RX7, P2RX3, P2RX1 | MAPT 3504/4885TDP1 2729/4885P2RY1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.